Immune monitoring

Oral

Dose-related Immunomodulation by Placenta-expanded, Mesenchymal Cells Improves Muscle Function Following Hip Arthroplasty: A Randomized Controlled Pilot Phase I/iia Trial

Friday, June 16
6:15 PM - 7:30 PM

No regenerative approach has thus far been shown to be effective in skeletal muscle injuries, despite high frequency and associated functional deficits. We sought to address surgical trauma related muscle injuries using local intraoperative application of allogeneic placental-expanded, mesenchymal-like adherent cells (PLX-PAD), using hip arthroplasty as a standardized injury model, because of their high regenerative and immunomodulatory potency. Our pilot phase I/IIa study was prospective, randomized, double blind and placebo-controlled. Twenty patients undergoing hip arthroplasty via a direct lateral approach received 3.0×108, 1.5×108 PLX-PAD, or a placebo into their gluteus medius muscle. We did not observe any relevant PLX-PAD-related adverse events at the 2-year follow-up. Improved gluteus medius strength was noted as early as week 6 in the treatment-groups. Surprisingly, until week 26 the low-dose outperformed the high-dose group and reached significantly improved strength compared to placebo, mirrored by an increase in muscle volume. Histology indicated accelerated healing after cell therapy. Biomarker studies revealed that low-dose treatment reduced the surgery-related immunological stress reaction more than high-dose. Signs of late-onset immune reactivity after high-dose treatment corresponded to reduced functional improvement. In conclusion allogeneic PLX-PAD therapy improved strength and volume of injured skeletal muscle with a reasonable safety profile. Outcomes could be positively correlated with the modulation of early postoperative stress-related immunological reactions.

Hans-Dieter Volk

charite, inst.med.immunology and bcrt

Presentation(s):

    Send Email for Hans-Dieter Volk

    Tobias Winkler

    bcrt/dept. orthopedics, charite university medicine

    Presentation(s):

      Send Email for Tobias Winkler

      Carsten Perka

      dept. orthopedics/bsrt, charite university medicine

      Presentation(s):

        Send Email for Carsten Perka

        Racheli Ofir

        pluristem

        Presentation(s):

          Send Email for Racheli Ofir

          Petra Reinke

          bcrt/dept. nephrology, charite university medicine

          Presentation(s):

            Send Email for Petra Reinke

            Esther Lukasiewiczs hagai

            pluristem

            Presentation(s):

              Send Email for Esther Lukasiewiczs hagai

              Georg Duda

              bcrt/jwi, charite university medicine

              Presentation(s):

                Send Email for Georg Duda


                Assets

                Dose-related Immunomodulation by Placenta-expanded, Mesenchymal Cells Improves Muscle Function Following Hip Arthroplasty: A Randomized Controlled Pilot Phase I/iia Trial



                Attendees who have favorited this

                Send Email for Dose-related Immunomodulation by Placenta-expanded, Mesenchymal Cells Improves Muscle Function Following Hip Arthroplasty: A Randomized Controlled Pilot Phase I/iia Trial